Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Escribano

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Allergy and Asthma Reports|July 11, 2006
Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatmentCem Akin, Peter Valent, Luis Escribano
Current Opinion in Pediatrics|July 14, 2012
Childhood mastocytosisAntonio Torrelo, Iván Alvarez-Twose, Luis Escribano
American Journal of Clinical Dermatology|June 15, 2011
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendationsMariana Castells, Dean D Metcalfe, Luis Escribano
Inflammation & Allergy Drug Targets|April 15, 2006
Current options in the treatment of mast cell mediator-related symptoms in mastocytosisLuis Escribano, Cem Akin, Mariana Castells, et al.
Journal of Cellular Biochemistry|July 7, 2007
STI571 (Glivec) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816Kristin Löber, Amparo Alfonso, Luis Escribano, et al.
Journal of Cellular Biochemistry|July 31, 2007
Influence of the tyrosine kinase inhibitors STI571 (Glivec), lavendustin A and genistein on human mast cell line (HMC-1(560)) activationKristin Löber, Amparo Alfonso, Luis Escribano, et al.
British Journal of Haematology|June 9, 2007
Recent advances in the understanding of mastocytosis: the role of KIT mutationsAlberto Orfao, Andrés C Garcia-Montero, Laura Sanchez, et al.
Methods in Cell Biology|July 5, 2011
Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disordersLaura Sánchez-Muñoz, Cristina Teodósio, José M Morgado, et al.
F1000Research|December 3, 2016
Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromesDavid González-de-Olano, Almudena Matito, Alberto Orfao, et al.
Immunology and Allergy Clinics of North America|August 26, 2006
Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell diseaseLuis Escribano, Andres C Garcia Montero, Rosa Núñez, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Allergy and Asthma Reports|July 11, 2006
Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatmentCem Akin, Peter Valent, Luis Escribano
Current Opinion in Pediatrics|July 14, 2012
Childhood mastocytosisAntonio Torrelo, Iván Alvarez-Twose, Luis Escribano
American Journal of Clinical Dermatology|June 15, 2011
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendationsMariana Castells, Dean D Metcalfe, Luis Escribano
Inflammation & Allergy Drug Targets|April 15, 2006
Current options in the treatment of mast cell mediator-related symptoms in mastocytosisLuis Escribano, Cem Akin, Mariana Castells, et al.
Journal of Cellular Biochemistry|July 7, 2007
STI571 (Glivec) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816Kristin Löber, Amparo Alfonso, Luis Escribano, et al.
Journal of Cellular Biochemistry|July 31, 2007
Influence of the tyrosine kinase inhibitors STI571 (Glivec), lavendustin A and genistein on human mast cell line (HMC-1(560)) activationKristin Löber, Amparo Alfonso, Luis Escribano, et al.
British Journal of Haematology|June 9, 2007
Recent advances in the understanding of mastocytosis: the role of KIT mutationsAlberto Orfao, Andrés C Garcia-Montero, Laura Sanchez, et al.
Methods in Cell Biology|July 5, 2011
Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disordersLaura Sánchez-Muñoz, Cristina Teodósio, José M Morgado, et al.
F1000Research|December 3, 2016
Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromesDavid González-de-Olano, Almudena Matito, Alberto Orfao, et al.
Immunology and Allergy Clinics of North America|August 26, 2006
Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell diseaseLuis Escribano, Andres C Garcia Montero, Rosa Núñez, et al.
Pageof 7